ID   RN19B_HUMAN             Reviewed;         732 AA.
AC   Q6ZMZ0; B7ZLB2; E9PAW6; G3XA82; Q0VG77; Q5TH44; Q5TH45; Q6P6A4;
AC   Q8N2S8; Q8WUF3;
DT   04-JAN-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 2.
DT   10-MAY-2017, entry version 129.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF19B;
DE            EC=2.3.2.- {ECO:0000250|UniProtKB:O60260};
DE   AltName: Full=IBR domain-containing protein 3;
DE   AltName: Full=Natural killer lytic-associated molecule;
DE   AltName: Full=RING finger protein 19B;
GN   Name=RNF19B; Synonyms=IBRDC3, NKLAM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, INDUCTION
RP   BY CYTOKINES, FUNCTION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Natural killer cell;
RX   PubMed=10438909;
RA   Kozlowski M., Schorey J., Portis T., Grigoriev V., Kornbluth J.;
RT   "NK lytic-associated molecule: a novel gene selectively expressed in
RT   cells with cytolytic function.";
RL   J. Immunol. 163:1775-1785(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 192-732 (ISOFORM 1).
RC   TISSUE=Embryo, and Esophagus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 133-732 (ISOFORM 2), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 170-732 (ISOFORMS 1 AND 4).
RC   TISSUE=Brain, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   ALTERNATIVE SPLICING (ISOFORMS 2 AND 4), AND TISSUE SPECIFICITY.
RX   PubMed=10912506; DOI=10.1007/s002510000182;
RA   Portis T., Anderson J., Esposito A., Kornbluth J.;
RT   "Gene structure of human and mouse NKLAM, a gene associated with
RT   cellular cytotoxicity.";
RL   Immunogenetics 51:546-555(2000).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH UBE2L3; UBE2L6 AND UCKL1.
RX   PubMed=16709802; DOI=10.4049/jimmunol.176.11.6454;
RA   Fortier J.M., Kornbluth J.;
RT   "NK lytic-associated molecule, involved in NK cytotoxic function, is
RT   an E3 ligase.";
RL   J. Immunol. 176:6454-6463(2006).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from
CC       E2 ubiquitin-conjugating enzymes UBE2L3 and UBE2L6 in the form of
CC       a thioester and then directly transfers the ubiquitin to targeted
CC       substrates, such as UCKL1. Involved in the cytolytic activity of
CC       natural killer cells and cytotoxic T-cells.
CC       {ECO:0000269|PubMed:10438909, ECO:0000269|PubMed:16709802}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000250|UniProtKB:O60260}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with UBE2L3, UBE2L6 and UCKL1.
CC       {ECO:0000269|PubMed:16709802}.
CC   -!- INTERACTION:
CC       P68036:UBE2L3; NbExp=2; IntAct=EBI-2466594, EBI-711173;
CC       O14933:UBE2L6; NbExp=3; IntAct=EBI-2466594, EBI-2129974;
CC       Q9NWZ5:UCKL1; NbExp=4; IntAct=EBI-2466594, EBI-2466660;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic granule membrane
CC       {ECO:0000269|PubMed:10438909}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10438909}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q6ZMZ0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6ZMZ0-2; Sequence=VSP_028635, VSP_028633, VSP_028634;
CC       Name=3;
CC         IsoId=Q6ZMZ0-3; Sequence=VSP_028632, VSP_028635, VSP_028633,
CC                                  VSP_028634;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q6ZMZ0-4; Sequence=VSP_028635;
CC   -!- TISSUE SPECIFICITY: Expressed specifically in natural killer
CC       cells, activated macrophages and cytotoxic T-cells. Present in
CC       natural killer cells (at protein level).
CC       {ECO:0000269|PubMed:10438909, ECO:0000269|PubMed:10912506}.
CC   -!- INDUCTION: In natural killer cells, by IFNB1/IFN-beta and
CC       IL2/interleukin-2 (at protein level).
CC       {ECO:0000269|PubMed:10438909}.
CC   -!- DOMAIN: The first IBR-type zinc finger is the most crucial for
CC       interaction with UBE2L3, UBE2L6 and UCKL1.
CC   -!- DOMAIN: Members of the RBR family are atypical E3 ligases. They
CC       interact with the E2 conjugating enzyme UBE2L3 and function like
CC       HECT-type E3 enzymes: they bind E2s via the first RING domain, but
CC       require an obligate trans-thiolation step during the ubiquitin
CC       transfer, requiring a conserved cysteine residue in the second
CC       RING domain. {ECO:0000250|UniProtKB:O60260}.
CC   -!- SIMILARITY: Belongs to the RBR family. RNF19 subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI13561.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAI43688.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=EAX07490.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK074486; BAC11017.1; -; mRNA.
DR   EMBL; AK131439; BAD18585.1; -; mRNA.
DR   EMBL; AL031602; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07490.1; ALT_INIT; Genomic_DNA.
DR   EMBL; CH471059; EAX07491.1; -; Genomic_DNA.
DR   EMBL; BC020595; AAH20595.2; -; mRNA.
DR   EMBL; BC062374; AAH62374.1; -; mRNA.
DR   EMBL; BC113560; AAI13561.1; ALT_INIT; mRNA.
DR   EMBL; BC143687; AAI43688.1; ALT_INIT; mRNA.
DR   CCDS; CCDS372.2; -. [Q6ZMZ0-1]
DR   CCDS; CCDS44107.1; -. [Q6ZMZ0-2]
DR   CCDS; CCDS72754.1; -. [Q6ZMZ0-4]
DR   RefSeq; NP_001120833.1; NM_001127361.2. [Q6ZMZ0-2]
DR   RefSeq; NP_001287755.1; NM_001300826.1. [Q6ZMZ0-4]
DR   RefSeq; NP_699172.2; NM_153341.3. [Q6ZMZ0-1]
DR   RefSeq; XP_006710419.1; XM_006710356.2. [Q6ZMZ0-1]
DR   UniGene; Hs.591504; -.
DR   ProteinModelPortal; Q6ZMZ0; -.
DR   BioGrid; 126065; 45.
DR   IntAct; Q6ZMZ0; 5.
DR   STRING; 9606.ENSP00000362555; -.
DR   iPTMnet; Q6ZMZ0; -.
DR   PhosphoSitePlus; Q6ZMZ0; -.
DR   BioMuta; RNF19B; -.
DR   DMDM; 160370005; -.
DR   MaxQB; Q6ZMZ0; -.
DR   PaxDb; Q6ZMZ0; -.
DR   PeptideAtlas; Q6ZMZ0; -.
DR   PRIDE; Q6ZMZ0; -.
DR   DNASU; 127544; -.
DR   Ensembl; ENST00000235150; ENSP00000235150; ENSG00000116514. [Q6ZMZ0-4]
DR   Ensembl; ENST00000356990; ENSP00000349482; ENSG00000116514. [Q6ZMZ0-2]
DR   Ensembl; ENST00000373456; ENSP00000362555; ENSG00000116514. [Q6ZMZ0-1]
DR   GeneID; 127544; -.
DR   KEGG; hsa:127544; -.
DR   UCSC; uc001bwm.5; human. [Q6ZMZ0-1]
DR   CTD; 127544; -.
DR   GeneCards; RNF19B; -.
DR   HGNC; HGNC:26886; RNF19B.
DR   HPA; HPA049587; -.
DR   MIM; 610872; gene.
DR   neXtProt; NX_Q6ZMZ0; -.
DR   OpenTargets; ENSG00000116514; -.
DR   PharmGKB; PA162401626; -.
DR   eggNOG; KOG1815; Eukaryota.
DR   eggNOG; ENOG410XP9Y; LUCA.
DR   GeneTree; ENSGT00840000129738; -.
DR   HOGENOM; HOG000059258; -.
DR   HOVERGEN; HBG052073; -.
DR   InParanoid; Q6ZMZ0; -.
DR   KO; K11973; -.
DR   OMA; WDITLAQ; -.
DR   OrthoDB; EOG091G0503; -.
DR   PhylomeDB; Q6ZMZ0; -.
DR   TreeFam; TF324777; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RNF19B; human.
DR   GenomeRNAi; 127544; -.
DR   PRO; PR:Q6ZMZ0; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116514; -.
DR   CleanEx; HS_RNF19B; -.
DR   Genevisible; Q6ZMZ0; HS.
DR   GO; GO:0044194; C:cytolytic granule; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IBA:GO_Central.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; EXP:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0000209; P:protein polyubiquitination; IBA:GO_Central.
DR   GO; GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR031127; E3_UB_ligase_RBR.
DR   InterPro; IPR002867; IBR_dom.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR11685; PTHR11685; 1.
DR   Pfam; PF01485; IBR; 2.
DR   SMART; SM00647; IBR; 2.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Adaptive immunity; Alternative splicing; Complete proteome; Immunity;
KW   Membrane; Metal-binding; Reference proteome; Repeat; Transferase;
KW   Transmembrane; Transmembrane helix; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    732       E3 ubiquitin-protein ligase RNF19B.
FT                                /FTId=PRO_0000084129.
FT   TRANSMEM    354    374       Helical. {ECO:0000255}.
FT   TRANSMEM    415    435       Helical. {ECO:0000255}.
FT   ZN_FING     119    166       RING-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   ZN_FING     186    251       IBR-type.
FT   ZN_FING     287    318       RING-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   COMPBIAS     29     32       Poly-Arg.
FT   COMPBIAS     41     97       Ala-rich.
FT   COMPBIAS     52     84       Pro-rich.
FT   COMPBIAS    625    630       Poly-Gly.
FT   ACT_SITE    302    302       {ECO:0000250|UniProtKB:Q9Y4X5}.
FT   VAR_SEQ      33    133       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_028632.
FT   VAR_SEQ     281    281       Missing (in isoform 2, isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:10438909,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_028635.
FT   VAR_SEQ     583    588       ECNNME -> FSMIHA (in isoform 2 and
FT                                isoform 3). {ECO:0000303|PubMed:10438909,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_028633.
FT   VAR_SEQ     589    732       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:10438909,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_028634.
FT   CONFLICT    284    284       I -> V (in Ref. 2; BAC11017).
FT                                {ECO:0000305}.
SQ   SEQUENCE   732 AA;  77925 MW;  EB30FBB46393C30B CRC64;
     MGSEKDSESP RSTSLHAAAP DPKCRSGGRR RRLTLHSVFS ASARGRRARA KPQAEPPPPA
     AQPPPAPAPA AAQGPPPEAL PAEPAAEAEA EAAAAAAEPG FDDEEAAEGG GPGAEEVECP
     LCLVRLPPER APRLLSCPHR SCRDCLRHYL RLEISESRVP ISCPECSERL NPHDIRLLLA
     DPPLMHKYEE FMLRRYLASD PDCRWCPAPD CGYAVIAYGC ASCPKLTCER EGCQTEFCYH
     CKQIWHPNQT CDMARQQRAQ TLRVRTKHTS GLSYGQESGP ADDIKPCPRC SAYIIKMNDG
     SCNHMTCAVC GCEFCWLCMK EISDLHYLSP SGCTFWGKKP WSRKKKILWQ LGTLIGAPVG
     ISLIAGIAIP AMVIGIPVYV GRKIHSRYEG RKTSKHKRNL AITGGVTLSV IASPVIAAVS
     VGIGVPIMLA YVYGVVPISL CRGGGCGVST ANGKGVKIEF DEDDGPITVA DAWRALKNPS
     IGESSIEGLT SVLSTSGSPT DGLSVMQGPY SETASFAALS GGTLSGGILS SGKGKYSRLE
     VQADVQKEIF PKDTASLGAI SDNASTRAMA GSIISSYNPQ DRECNNMEIQ VDIEAKPSHY
     QLVSGSSTED SLHVHAQMAE NEEEGSGGGG SEEDPPCRHQ SCEQKDCLAS KPWDISLAQP
     ESIRSDLESS DAQSDDVPDI TSDECGSPRS HTAACPSTPR AQGAPSPSAH MNLSALAEGQ
     TVLKPEGGEA RV
//
